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DEVELOPMENT OF COMPUTATIONAL TOOLS TO TARGET MICRORNA
STRUCTURE MOTIFS
Luo Song, B.S.
Advisory Professor: Shuxing Zhang, Ph.D.
With the advance of computational technology and theory, Computer-Aided
Drug Design (CADD) has become an irreplaceable and efficient way in the industry
for drug development. Massive virtual screening of small molecules to targeting
aimed protein or nucleotides in a relatively short period is the major advantage of
CADD. Based on existing models, researchers are able to evaluate the binding
affinity of the target and ligands. Then, one or several hit compounds could be
chosen for further experimentally test. This whole process would save both
considerable time and funding of pharmaceutical companies or organizations.
In Human cells, only around 2% of all transcriptional output is message
RNA. The rest, as non-coding RNAs, always play a crucial role in cellular activities
such as post-translation modification processes. Any abnormal transcription of
RNAs may result in a large multitude of related diseases, like cancers. Thus, RNA
regulation pathway or RNA-related drugs are trending.
Non-coding RNAs, in particular miRNAs, play an important role in disease
development and treatment. However, structure-based computational methods still
remain challenging in accurately predicting RNA-small molecule interactions. In
order to improve the prediction accuracy, our laboratory has developed integrated
approaches to screening for RNA inhibitors, including AutoDock, GOLD and so on.
Meantime, parameters of scoring function were modified based on RNA-small
molecule binding affinity data set training, named iMDLscore.
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My objective is to further improve the RNA-small molecular interaction
prediction accuracy in order to better assist potential drug screening. The project
starts with providing a tool for better finding potential miRNA targets with desired
motifs. We primarily combined the sequences information of miRBase and structure
information from PDB (Protein Data Bank) database. To better assist motif
searching process, the primary structure was converted into 2D structure based on
present prediction tools, including RNAstructure. Once got initial impression of the
RNAs, our project further provides a detailed example of miRNA dynamics study
and small ligands binding affinity study. This step will help user finding more
chemical information about the RNAs. Last but not least, in order to better
evaluating the binding affinity of small ligands, the scoring function of docking
process is one of the most crucial parts for precise prediction. RNAs, as negatively
charged molecules, tend to be more dependent on electric interaction than neutral
molecules. To obtain a more precise result, we have induced the combination of
Yukawa and Coulomb potentials. Yukawa potential is a short-range potential which
caused by the influence of mobile ions and solvent. When the distance between two
atoms is larger than 3 angstrom, Yukawa potential would have a contribution to the
interaction. I used a proper RNA data set to process the multi-linear regression
method and deep learning, including convolutional neural network (CNN) and long
short-term memory (LSTM) neural network to obtain desired models. The result
shows LSTM has the overall best outcome with 0.967 of R-square value and, 1.42
kJ/mol, prediction root mean standard error (RMSE).
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Chapter 1: Introduction
1.1 Overview of RNA in Bioprocess
RNA molecules are polymers consisting of four nucleotides with the same
sugar-phosphate backbone and four various bases which are Adenine (A), Guanine
(G), Cytosine (C) and Uracil (U). RNAs can be divided into different categories
based on their role involved in different biological process. Based on whether the
transcribed RNA could be translated to proteins, RNAs are divided into massager
RNA (mRNA) and non-coding RNA. According to the length and biological role,
non-coding RNAs are further divided into long noncoding RNA (lncRNA), rRNA,
tRNA, microRNA (miRNA), small nuclear RNA (snRNA), small nucleolar RNA
(snoRNA) and so on. Actually, only around 2 percent of transcribed RNAs belong to
coding RNAs and the majority of RNAs are non-coding RNAs which have great
contribution to cell stability and proliferation [1-3].
Looking back to the whole cellular biological process in any type of cells,
various RNAs always play a crucial role in each steps which include DNA
duplication [4-6], transcription, translation and post-translation modification
processes [7, 8]. These RNAs may interact with DNAs [9-11], proteins [10, 12, 13],
or even RNAs [10] to participate in precise and vest cellular metabolism process.
Due to the essential role of RNAs, any unexpected interruption and abnormal
enhancement of RNAs functionality regulation may result in a large multitude of
related diseases, like cancers [14-19].
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With reverse thinking, we can also come up with an idea that developing new
drugs to target disease-related RNAs, especially non-coding RNAs. In fact,
scientists from different scientific area have put a large amount of efforts into the
disease-related non-coding RNA researches [3, 6-8, 14-19]. In the following
introduction, I will present you several part of the current progress about noncoding RNA discovery.

1.2 Non-coding RNA and Diseases
Increasing evidence has shown that extraordinary number of non-coding
RNA related to certain disease, which including cancers [14-19], central nervous
system disorders [20-22], cardiovascular diseases [23, 24]and so on. Different type
of non-coding RNA, due to their various fundamental role involved in the
metabolism processes, has been proven to be linked to various human diseases. For
instance, snRNA may be involved in pre-mRNA splicing and lncRNA may related
to the regulation of protein-coding genes, including oncogenesis.
1.2.1 Non-coding RNA in Cancer
Cancer, as one of the highest mortality-rate disease, is always the centric of
biomedical research in past decades. The discovery of connection between noncoding RNA and cancer always gives the scientists a new aspect to find approaches
to treat cancer.
Long non-coding RNA (LncRNA) is one important type of con-coding RNA
which is classified by their sizes and has larger size than 200 bps. Although there is
only a relatively short history of lncRNA biology study, fast-growing sequencing
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technology really boosts the identification of LncRNAs. According to database
NONCODE [25], 172,216 entries of transcripts of human LncRNAs has been
reported and 96308 entries of human LncRNAs genes has been found until now,
while the number may still grow in the future.
The current idea of main function of LncRNA is focus on the role that
involved in the regulation of gene expression. The aberrant expression of lncRNA
may be leads to or as a biomarker for certain type of cancers. For example, it has
been reported [26] that Linc00974 was involved in hepatocellular carcinoma (HCC),
meanwhile, it had a relatively high positive correlation with KRT19 gene which was
recognized as HCC progression-associated factor, which also explained the reason
why Linc00974 had a potential to promote HCC cells proliferation and invasion.
Another study [27] also found Linc00974 upregulate CDK6 to promote the
proliferation of gastric carcinoma.
Besides lncRNAs, miRNAs play a crucial role in the cell life activity, as
well. Under normal circumstances, miRNAs mainly act as sequences-specific guides
for RNP[28]. Due to the different type of target, miRNAs may have different effect
on the cell metabolism regulations. When miRNAs binding to protein-coding
mRNAs, it may decrease the expression of the certain proteins[29]. At the same
time, miRNAs are also able to bind to other type of ncRNAs[30], which may have a
negative effect on the expression of target ncRNAs. Because of the functionality of
miRNAs, it is not difficult to realize there is a huge potential for miRNAs to have a
significant impact on cancer progression and invasion.
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Until today, scientists has been put a significant efforts to discover the role
of miRNAs in cancer development [31]. In bioinformatics, a published database,
called miRBase [32], has included nearly 2000 human microRNA sequences with
annotations. Meanwhile, there are also plenty experimental based evidence which
confirmed the role of miRNAs in cancers. For example, studies [33] has been
performed to prove that miR15A/16-1 cluster [34], miR21 [35], miR155 [36] and
some other miRNAs were related to lymphomagenesis. Besides, let-7 had been
confirmed as a tumor suppressor in cell. The reduction of expression would leads to
the low survival of lung cancer patients[37]. Similarly, miR-29b was also proven to
relate to ovarian serous carcinoma [38-40].
The function of snRNAs is conceptually similar to miRNAs, where both of
them act by complementally binding to target sequence and associating with other
protein or enzymes. snRNAs were primarily used to aid post-transcription
modification of mRNAs. A recent study has revealed that there is a conserved
mutation of U1 snRNA occurred in several tumor types. The mutation may directly
lead to alteration of splicing pattern of multiple genes expression [41].
1.2.2 Non-coding RNA in other diseases
Besides cancer, there are also increasing evidence showing that non-coding
RNAs, especially miRNAs, are involved in various human disease[31]. According
to recent reviews, different miRNAs may related to diabetes[42], cardiovascular
disorders[43], neurological disorders[21], kidney disease[44].
snorRNAs were also very crucial in the development of human disease. One
type of snorRNA, HBII‐52 [45], was found that the loss would impact the
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alternative splicing of pre-mRNA of serotonin receptor. Meanwhile, there are some
evidences to support the relationship between snorRNA and imprinting disorders,
such as Prader–Willi syndrome.
Efforts are still needed to be put into the discovery of ncRNA. With mining
more information of ncRNA out, much more alternative approach of treatments
would be revealed in the future.

1.3 RNA motifs
RNA linear chains can fold into one or multiple stem-loop double helix
structures by hydrogen bond, which called secondary structure. The double helix
region mainly follows Watson-Crick paring rules (A-U and G-C). There are two
main different categories of RNA secondary structure, stem and loop. A stem is a
double helix region formed by the stacking of two or more consecutive base pairs. A
loop is a single stranded region formed by the stacking of one or more consecutive
base pairs. Additionally, the secondary structure further fold into a threedimensional structure. RNA motifs consist of discrete sequences or pair of base
juxtapositions found in RNAs under physiological conditions. The complementary
sequence of RNAs will be folded to form double helix, even for short length RNAs.
Normally, RNAs can transited into one or several hairpin structures. Meanwhile,
Watson-Crick complementarity is not strictly conserved in the stem of the hairpin.
Unpaired bases and non-Watson-Crick pairings are also observed in their helices.
These structural elements together called RNA motifs.
The RNA motifs presented in stem-loop structure can be divided into two
main classes: terminal loop motifs and internal loop motifs. A terminal motif is the
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motif which formed by RNA folding back on itself and some of the bases not
forming Watson-Crick pairs. For terminal motifs, U-Turn was the first terminal loop
motif identified, and it usually occurs in tRNAs. Besides, in the ribosome RNAs, the
existence of tetraloops, which is another terminal motif, was revealed in 1980s.
An internal loop motif is a run of bases which are not able to form WatsonCrick pairs with the opposite strand. For internal loop motifs, it mainly includes
bulge loop which is a single stranded region which interrupts a stem on one side.
And an interior loop interrupts a stem on both sides. According to the length of loop
sides, interior loop also can be divided into symmetric and asymmetric interior
loops. Meanwhile, mismatch may also occur during the RNA folding due to noncanonical pair.
RNA binding mode varies due to different targets. They usually bind with
nucleic acid through base pairing and other macromolecules or small ligands
through specific section or specific motif interaction. For example, TAR loop in the
HIV tends to have high affinity to form ternary complex with CycT1 and Tat.
According to the paper published in 2002, CycT1-Tat directly binds to U-rich bulge
region of TAR, which is required for replication of human immunodeficiency virus
(HIV). Meanwhile, A35 or C35, which forms a single-nucleotide bulge, contribute
to distortion of the RNA backbone. Based on the information above, the motif can
be designed as a specific target for small molecular drugs binding. Iron responsive
elements is another example of motif related interaction case. It locates on
untranslated mRNAs regions which has potential to binding with iron regulatory
proteins in response of iron starvation. RNA motif normally highly related to their
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function. Changes or mutations in motif structure may alter its function. For
example, in the case of CycT1-Tat complex, if mutation occur in G34 in TAR loop,
the binding affinity of CycT1-Tat complex and TAR loop would be negatively
affected. Meanwhile, change of U31 and G33 also affect the stability of RNAprotein complex. Due to the importance of RNA motif, it is valuable to develop
computational tools or database to assist RNA motif research in the area, especially
in drug screening and development.

1.4 Computer-Aided Drug Design
With the development of computational technology and theory, including
mathematics model and theoretical chemistry, Computer-Aided Drug Design
(CADD) has become a popular and efficient way in the industry for drug
development. The main advantage of CADD techniques is that a massive database
of small molecules are able to be examined in the virtual screening[46]. Meanwhile,
researchers can also design their own interested novel compounds with the help of
computational tools. Based on existing models, computer may evaluate the binding
affinity of the target and ligands. Based on the calculated affinity, one or several hit
compound would be chosen for further experimentally test.
There are two categories for CADD [46]: structure-based and ligand-based.
The structure based CADD mainly focuses on the knowledge and theory of the
target macromolecules, including protein, DNA, RNA and so on. However, the
ligand based CADD tried to use the information of known active and inactive
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ligands to predict other potential effective compounds through chemical similarity
searches.
According to different idea of drug design, various docking methods would
be used for each category. For structure based CADD, we mainly use empirical free
energy scoring functions which are based on physical interaction terms. Assumption
is made that target-ligand binding affinities are directly related to a sum of
individual parameters which represent the potential energy between target molecule
and ligands, like hydrogen bonds or electrostatics. For ligand-based CADD, current
scoring methods is mainly knowledge-based functions which developed by using
statistics methods for database of known crystal structure of receptor-ligand
complexes.

1.6 Molecular Docking
Based on “lock-and-key” model, molecular docking is used to predict the
orientation of one molecular to another. Nowadays, it has become an important part
of drug discovery tools. The obvious advantage of the molecular docking is that
researchers can easily screening thousands of ligands with certain prediction model.
It significantly reduced the cost of money and time for pharmaceutical research and
development(R&D).
A review [47] in 2017 has revealed that more than 60 docking tools and
programs had been developed in silico to boost drug discovery industry or academic
research in past two decades. DOCK [48], GOLD [49], MOE-Dock [50], AutoDock
[51] and AutoDock Vina[52], for instance, were commonly used in this field.
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Docking software are consisting of two main parts: searching algorithm and
scoring function. The searching algorithm is the part where various conformations
of ligands were produced in an optimum manner. In this part, spatial configuration
and relative position are determined in order to further binding affinity calculation.
Once the conformation is produced, the scoring function will be used to
evaluate the binding affinity of the complex. The feedback from the evaluation
impacts the subsequent searching algorithms. The docking process will finish once
the searching algorithms reach the threshold condition which varies depending on
different theories.
Scoring function is the mainly tool used to evaluate the interaction between
receptors and ligands. Current popular docking software may likely to use empirical
free energy scoring functions during the docking process, however, the parameter of
potential energy and approach how they use it may be various from software to
software. For example, the scoring function of rDock [53] is similar with AutoDock
Vina which only use the scoring function once with the full scoring function during
docking process (as shown in Fig 1.1). However, their parameters of free potential
energy are different with each other. In AutoDock Vina, the scoring function mainly
consist of three parameters, gauss1, gauss2 and repulsion. But the scoring function
of rDock is ! !"!#$ = $% ! &'!() + $* ! &'!)# + $+ ! ,&!( + $- ! )(,!)#&'! , with $%.- as
weight of each parameters, ! &'!() as receptor-ligand interaction score, ! &'!)# as
energy difference due to ligand conformation change, ! ,&!( as relative energy of the
flexible regions of active site and ! )(,!)#&'! as a collection of non-physical restraint
function. Even more, the scoring function of AutoDock4.2 [54] is different than
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AutoDock Vina. However, instead of using full scoring function, some docking
software, like GOLD and DOCK, choose to have two stage scoring function. As
illustrated in Fig 1. 2, The first stage scoring function, less accurate and less
computationally expensive, is combined with searching algorithms to speed the
searching process up. The second stage scoring function includes more details to
describe the interactions and thus the result would need more computing power but
is more accurate in return.
No matter how different the docking software tools are, most of them were
developed to predict the binding site or binding affinity of protein-small molecules
interaction or protein-protein interaction. Only a limited number of docking
programs were specially developed for RNA-small molecules interactions.
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Fig 1. 1 Workflow of one-stage docking software.

Fig 1. 2 Workflow of two-stage docking software
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1.5 RNA Ensemble Modeling
The variations in conformational state of RNA plays a critical role in
complex cellular metabolism pathways and in the control of gene expression.
Normally, a cellular signal will trigger the RNA dynamics and then, it will be
transduced into a specific biological output.
Proteins are commonly the triggers of RNA conformational transitions. They
stabilize one or a set of RNA conformations by specifically binding to their target
RNAs. Meanwhile, protein binding also causes large changes in the overall
orientation of RNA structures around junction motifs. For example, the
spliceosomal U4 snRNA goes through a large transition in the interhelical bend
angle when it binds to its protein target.
However, a major challenge in determining conformation ensembles is that
the number of parameters needed to specify the structure and the population weights
of all conformers is huge comparing to the number of the experimental data we can
measure. Fortunately, residual dipolar couplings (RDCs), which are measured by
solution nuclear magnetic resonance (NMR) spectroscopy, provides a rich source of
information for ensemble conformation construction and validation.
A research has conducted by using two sets of RDCs measured in elongated
transactivation response element (TAR) RNA from the human immunodeficiency
virus type I (HIV-1) to obtain a set of ensemble structures. 80 ns molecular
dynamics (MD) trajectory of TAR was firstly produced, and then, the RDCs were
used to guide selection of conformers from a snapshots pool from the trajectory.
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Meanwhile, another study revealed that X-ray scattering interferometry,
which is based on site-specifically labeling RNA with pairs of heavy atom probes,
can also be used to determine RNA conformational ensembles as well. The
technology precisely measured the distribution of inter-probe distances.
With improving importance of dynamic view of RNA, we also need to
further strength our basic understanding of RNA dynamic behavior. There is still
limited experimental data regarding to even well-studied RNA molecules such as
tRNA. More efforts should be addressed in the future for better revealing cellular
mechanism.
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1.8 Hypothesis and Specific Aims
With substantial progress in RNA biology, non-coding RNAs, in particular
miRNAs, play an important role in disease development and treatment. However,
structure-based computational methods still remain challenging in accurately
predicting RNA-small molecule interactions. In order to improve the prediction
accuracy, our laboratory has developed integrated approaches to screening for RNA
inhibitors, including AutoDock, GOLD and so on. Meantime, parameters of scoring
function were modified based on RNA-small molecule binding affinity data set
training, named iMDLscore.
My main hypothesis is that with combination of current databases and
computational tools, we may develop new efficient approaches for RNA-small
molecule interaction research and drug discovery. My objective is to develop new
methodologies which assist the study of RNA structure including miRNA motif
screening, ensemble conformation generation, and new scoring functions to further
improve predictions of RNA-small molecular interactions. In order to better predict
the dynamic structure of RNAs, it was critical to generate the ensemble conformers.
After the conformers are generated, it is also necessary to quantitatively assess the
interaction between RNAs and ligands. In this step, scoring functions play an
irreplaceable role in binding affinity study. Scoring is one of the most crucial
components in the docking process. RNAs, as negatively charged molecules, tend to
be more dependent on electric interaction than neutral molecules. However, the
scoring function used to calculate electric interaction in AutoDock 4.2 is relatively
coarse, while only electrostatic potential energy is calculated. To obtain a more
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precise result, we have induced the combination of Yukawa and Coulomb potentials.
Yukawa potential is a short-range potential which caused by the influence of mobile
ions and solvent. When the distance between two atoms is larger than 3 angstrom,
Yukawa potential would have a contribution to the interaction. My central
hypothesis is that inducing Yukawa potential will lead to more accurate prediction
in the RNA-small molecular interaction. If this hypothesis is correct, the new
scoring function will be used in re-scoring the docking results. Meanwhile, to better
aid the drug development process, it is also important for users to screen out the
brunch of miRNAs which may contain same motif, in that case, we may have a clue
about the potential specificity and side effect that the small molecules may cause.
By pursuing the following specific aims, we will develop a new scoring
function. Furthermore, I will also use a proper RNA data set to process the multilinear regression method and deep learning to obtain all the parameters of the
equations. Meanwhile, to better understand the functions and abundance of a
particular motif, we will implement a motif screening tool. To this end, I will build
several databases of miRNA secondary structure based on different prediction tools
and develop a fast, efficient strategy to screen the motif throughout the databases.
Aim 1: Develop a user-friendly webserver to screen critical motifs in
miRNAs.
I had collected the while miRNAs primary sequence from miRBase and built
several database of miRNAs secondary structures by using different prediction
tools. Meanwhile, a software which was written in Python had been developed for
the searching process. Furthermore, for better visualization of the structure of the
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target motif, all available RNA 3D structure from RCSB Protein Data Bank had
been download and converted to 2D structure. As an additional option, if there is
any match found, users would be able to get insight about the motif based on known
similar 3D structures of RNAs.
Aim 2: Conduct structure ensemble-based molecular discoveries by
targeting crucial RNA motifs.
In order to generate conformation ensembles for RNA, I firstly used
Molecular Dynamics to produce 100 ns movement and 50,000 snapshots. Then, I
implemented EnsembleGen to select a set of conformations as ensembles based on
experimentally measured RDC values.
With the selected ensemble structures, I performed molecular docking to
evaluate the interactions of our small molecule inhibitors with our interested UUGA
RNA motif and analyze their binding patterns.
Aim 3: Develop a novel Yukawa potential-based scoring function to
evaluate RNA-small molecule interactions.
I firstly collected RNA-ligand binding affinity dataset from PDBBind as
training and validation dataset. Meanwhile, I also used molecular dynamics to
generate restricted dynamic structure to increase training sample size and improve
stability and performance of training result.
Then, various model training methods were used, including multi-linear
regression, Convolutional Neural Network (CNN), Long Short Term Memory
(LSTM). The result was compared to get an overall best model for further use.
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1.7 Summary
RNA is essential in every step of cellular pathways. Different type of RNAs
paly a various role in metabolism process. Some of RNAs convey the genetic
message from nuclear to ribosome, some of RNAs regulate the expression of gene,
and some of RNAs consist of specific organelle, such as ribosomes. With the reveal
of functionality of each RNA types, scientist start to realize the importance of RNA
related research and put numerous efforts into it. However, due to the limitation of
experimental methodologies and equipment, there still is a large gap to fulfill.
When studying the model of RNA and small molecules interaction, RNA
motifs are always the key position where interaction happened. Thus, it is important
that we can find corresponding RNAs that contain certain motif sequence in the real
world, especially in the human body. Based on this demanding, in chapter 2, I
developed a miRNA motif searching webserver called, miRmo. The webserver can
help user find corresponding miRNAs with certain secondary structure motifs and
PDB RNA 3D structures.
After getting target miRNA secondary structures from screening webserver,
in order to obtain binding ligands via docking process, it was necessary to generate
accurate structure of miRNAs. To enrich the method of RNA studies, our lab has
developed a home-made software called EnsembleGen which can be used to select a
group of ensemble conformers from a pool of structures based on RDC dataset.
Thus, I try to apply this application on a specific artificial miRNA ensemble
structure generation and structure study in Chapter 3. The pool of structures was
generated by molecular dynamics (MD). Based on the RNA structures, I further
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studied the binding affinity between the ensemble structure and pre-identified
ligands. Last but not least, to better descript the binding affinity between RNAs and
small molecules, I further developed a new scoring function by inducing Yukawa
potential into AutoDock 4.2 scoring function in Chapter 4. The new scoring
function was trained by several various methods, including multi-linear regression
and deep learning.
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Chapter 2: miRmo: An Efficient Non-Paired RNA Motif
Screening Web Server
2.1 Introduction
MiRNAs (miRNAs) are short, non-coding RNAs which regulate posttranscriptional modification. It has been shown to play important role in various
human diseases [55], including cancer [56-58], vascular diseases [59, 60], and
obesity related metabolic disorders [61-64]. MiRNAs are involved in corresponding
cellular pathway of pathologies. MicroRNAs and their precursors have distinct
secondary structures and have become popular potential targets for disease
treatments. Pre-miRNAs are the precursor of miRNAs which have relatively longer
length than miRNA and normally forms intra-molecular paring. For the secondary
structure of pre-miRNAs, they commonly have multiple non-paired secondary
structures with fixed patterns (e.g. hairpin, bulge, mismatch and internal loop) and
includes two part: terminal loop and stem portion. The terminal loop is a hairpin
structure, while several different motifs can also present in the stem parts, including
bulge, internal loop and mismatch. These motif structures can play important roles
as potential binding sites for small molecules.
Screening of structural motifs is a major challenge in accelerating drug
discovery efforts targeting pre-miRNAs. As per our knowledge, current motif
searching tools mainly focus on finding the motifs in specific miRNA sequencing
databases, such as high-throughput dataset [65]. In previous decades, RNA motif
searching algorithms and tools were developed based on different aspect and
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mechanisms. Some tools, such as Infernal, use covariance models (CMs) to create a
probabilities profiles of the sequence and the secondary structure based on known
related RNA families. The advantage of this method is that it commonly good at
revealing the important part of motif for a particular RNA group. However, in order
to gain accurate models, users have to provide known RNA families structure in
order to train the probabilistic models. this is usually not the case in real world. By
contrast, RNAmotif from Case group was developed to screen the RNA database
with aimed motif structures based on user-defined descriptors which means that
users are available to describe their aim motif and pairing standard by themselves.
[66]. It was considered as one of the most popular RNA secondary structure motif
searching algorithm, has large flexibility for users to define their own base pair
rules and motifs. The limitation of RNAmotif is that users have to know basic Linux
knowledge and write their own script to achieve searching process. Meanwhile,
users have to provide their own database for the algorithm. Another popular RNA
motif searching tools was RNArobo which combined the sequence and structure
constraints to dig out potential functional RNAs. These tools are specifically useful
for complex RNA secondary structures which were not able to be predicted by using
simple thermodynamic models. Unlike ribozymes and rRNA subsets, pre-miRNAs
are relatively short and simple RNAs which, in my opinion, is suitable for
thermodynamic models for prediction to get a robust prediction result. Thus, we can
caustically apply thermodynamic models-based prediction methods on pre-miRNA
secondary structure prediction. To enrich the diversity of searching algorithm and
increase user experience for non-computational professions, we sacrifice some
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unnecessary features and developed a user-friendly miRNA screening webserver
which mainly contains two-part, database and searching algorithms.
The primary sequence database, which obtained from miRBase [67], contains
271 species and 38503 entries. Secondary structures which are predicted by three
secondary structure prediction software, including RNAstructure [68], RNAfold
[69] and CentroidFold [70]. RNAstructure was developed based on thermodynamics
models with nearest neighbor parameters from Turner groups. RNAfold is a tool
from ViennaRNA package, which computes the minimum free energy (MFE) and
backtracks to obtain an optimal secondary structure. The last complementary tool
we used in our webserver is CentroidFold. It predicted RNA secondary structure
based on a posterior decoding method. Three different prediction tools were used to
build the database so that users can pick their favorite choice, or they may also
compare the difference between each prediction result to gain robust and confident
searching result.
Our algorithm was written in Python and it is able to screen microRNA based
on different type of motifs, including hairpins, internal loops, bulges and
mismatches. To better assist users to visualizing how their target motif potentially
look like, we also build a RCSB PDB 2D RNA structure database by DSSR
(Dissecting the Spatial Structure of RNA) [71]. DSSR is a powerful tool which had
been integrated multiple functions to analyze and annotating RNA 3-dimention
structures, including converting 3D structure into 2D formats. They also have tested
the software for all nucleic acid structures in the PDB database. With the whole
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package above, miRmo webserver would provide users a convenient and
comprehensive screening process.
In order to shorten screening time, secondary structure databases were
constructed and stored in array file in advance. As an improvement of previously
available tools, miRmo directly search secondary structure of miRNA instead of
primary structure. Meanwhile, a user-friendly inter-face were designed by our group
to assist users to choose corresponding motif type, dataset, and type the input.
Detailed instruction is also available on the website. Besides miRNA structures,
experimentally derived 3D structure of RNAs in PDB database are available as well.
This feature may help users to have a whole picture of motif structure.

2.2 Material and Methods
Our web server mainly contains two-part, database and algorithms. To
building up miRNA database, as shown in Fig 2.2, we obtained the whole updated
miRNA primary sequences, as an EMBL format file, from miRBase and convert it
by a home-made bash script to FASTA format in order to proceed further prediction.
The accession numbers, sequence identifiers and species information are remained
in the FASTA file. In EMBL format file, each miRNA entries were separated by
“//”. By using this pattern, each miRNA was easily extracted from the script.
Meanwhile, for each entry of EMBL file, “ID” line stands for sequence identifiers,
“AC” line stands for accession numbers and “DE” stands for species information.
With these pattern, each entries information could be split and recombined into
FASTA format files.
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Based on the miRNA primary structures, Secondary structures were
predicted by RNAstructure, RNAfold and CentroidFold, then saved as CT format
files. Only highest-score prediction results were kept for further screening purpose.
Meanwhile, under the assumption that users may be much more frequently
interested in Homo sapiens, we created two independent database option, Homo
sapiens and all species, for users to choose, since time consuming will be much
short due to only 1919 Homo sapiens entries exist in the database.
After miRNA secondary structures predicted, RNAstructure package
continue to be used for generation of 2D image and the images were stored as PNG
format. The architecture of database was shown in Fig 2.1.
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Fig. 2. 1 Architecture of miRNA 2nd structure dataset. The FASTA were used by
3 different prediction tools (RNAstructure, RNAfold, and CentroidFold) to predict
the secondary structure which written as CT format. 2D Image also generated.
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Download from PDB
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into FASTA format

Obtain secondary
structure as .ct files
Arrange by
prediction
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Arrange Homo
Sapiens as
additional folder

Separate multiple
chains into single file

Fig. 2. 2 Illustration of workflow of building databases: A. miRNA secondary
structure dataset. Starting from EMBL format primary sequences; B. PDB database.
Starting from 3D structures.
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For RCSB PDB RNA database, we obtained the whole available RNAs in
PDB format from Protein Data Bank website (https://www.rcsb.org/). In the
database, advance searching was processed with condition “Polymer Entity Type”
and “RNA”. All related files were download as PDB format. Then, 3DNA DSSR
was used to perform structure analysis and annotation for the RNAs and,
meanwhile, convert PDB format (3D) to CT format (2D). The CT files with multiple
chains (numbers) were separated for searching purpose by home-made software.
The screening algorithm was based on the idea of alignment. To better fit
into the webserver, the python algorithm file took three arguments as input. Aimed
to describe the secondary structure of desired motifs, users need to input the lefthand side of motif sequence and right-hand side of the motif sequence in the order
from top to down, separately. There is no hard rule to determine which side is left or
right. The direction here is just for illustration.
Meanwhile, the webserver offers different options for users to freely specify
the database by choosing prediction tools and species. It is also necessary for the
webserver to take in the type of motifs which users want to screen, which including
Internal Loop, Mismatch, Bulge and Hairpin. The options for prediction tools are
RNAstructure, RNAfold and CentroidFold. There are two options of species: Homo
sapiens and Complete Database.
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Fig. 2. 3 Screenshot of Webserver Input Interface. The interface includes 1. input
of Strand1, 2. Strand2 sequence, 3. Choice of database, 4. Choice of prediction
software, 5. Target motif type and 6. Choice of whether process PDB searching.
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Once every argument is specified by users, example as shown in Fig 2.3, the
webserver is able to load the database and start screening process. Firstly, the
programs will find the alignment of the left-hand side of motif sequence and check
if the right-hand side one matches with the sequence in the opposite of alignment, as
well. When the program finds the both matches, the information of miRNA will be
printed as an output. If there is no result in the first searching turn, the algorithm
will exchange the left- and right-hand side motif sequence and process another
round of searching. If this round also fails, the algorithm will reverse the motif
sequence and repeat the process mentioned above. The algorithm is designed to
screen every possibility that may occur in the real world.
After finishing the screening process, a table will be printed on the web page.
Each entries of the table will provide information about name of the miRNA,
species which the miRNA comes from, a link for users to download the CT format
file of miRNA, another link for users to visualize the selected miRNA and the
location of aimed motifs.
Frontend of the miRmo is developed in HTML and JavaScript while serverside scripts are written in PHP and Python (version). miRmo algorithm is developed
as python scripts and executed using GNU Parallel [54].

2.3 Result
The dataset was well organized by prediction tools and species. We proceed
a motif screening example by using our specific interest motif “UU:GA”. The inputs
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of webserver are not capital sensitives or direction sensitive, which means the
webserver is able to find every possible result through the screening process.

2.3.1 Data set
The dataset, which was collected from miRbase contained 38503 entries,
including 1919 Homo sapiens microRNAs. Meanwhile, the microRNA sequences
were from 271 organisms. Each entry was converted to secondary structure which
recorded in a CT format file. As shown in Fig.2.4, the number of Homo sapiens
entries is the most abundant in miRBase. The second large group is mouse which is
also the major focus of biomedical research. Among top 20 species, most of the
species has pre-miRNAs whose average length is below 100 bp. Only few species
have more than 100 bp average length of miRNAs. But, all of miRNAs, as shown in
Fig. 2.5 are below 300 bp.
The whole secondary structures were predicted by RNAstructure, RNAfold
and CentroidFold, respectively. For each tool, the secondary structure prediction
result of Homo sapiens miRNAs was duplicated into an independent directory as
optional choice for users to choose.
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Fig. 2. 4 Number counts of miRNA for Top 20 species in miRBase.
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Fig. 2. 5 sequence length of top 20 counts species.
By advanced searching in RCSB PDB website, 4596 RNA structure entries
were found in result. All of them were downloaded and con-verted to 2D structure
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as CT format. Due to part of entries were bundled by several PDB structure, there
were 5656 CT files of RNA secondary structures after conversion. Furthermore, the
CT files with several RNA chains were split for better screening. Finally, there were
16640 CT files in RCSB PDB 2D RNA structure database.
2.3.2 Illustration and Example
The screening algorithm was based on the idea of alignment. Aimed to describe the
secondary structure of desired motifs, users need to input the left-hand side of motif
sequence and right-hand side of the motif sequence in order from top to down,
separately. Meanwhile, the webserver offers different options for users to freely
specify the database by choosing prediction tools and species. It is also necessary for
the webserver to take in the type of motifs which users want to screen. Once every
argument is specified by users, the webserver is able to load the database and start
screening process. Firstly, the programs will find the alignment of the left-hand side
of motif sequence and check if the right-hand side one matches with the sequence in
the opposite of alignment, as well. When the program finds the both matches, the
information of miRNA will be printed as an output.
After finishing the screening process, a table will be printed on the web page. Each
entries of the table will provide information about name of the miRNA, species which
the miRNA comes from, a link for users to download the CT format file of miRNA,
another link for users to visualize the selected miRNA and the location of aimed
motifs.
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For our specific interest of motif “UU:GA”, we consider two situations may be the
most possible, internal loop or mismatch. According to the rule of input, on the lefthand side, the input was “ug” and on the right-hand side, the input was “ua”. “Homo
sapiens”, “RNAstructure” and “internal loop” options were choosing as screening
condition. As a result, 24 entries of Homo sapiens miRNA which contain “UU:GA”
internal loop motif were discovered, shown in Fig.2.6B. When different prediction
tools chose, the result may be different. For instance, the result of “UU:GA” motif
searching in RNAfold prediction result has 33 queries. However, there are only 4
entries in CentroidFold prediction dataset.
For instance, as shown in Fig.2.6C, miR-153-2 is the first entries of screening result,
we provide the secondary predicted structure as shown in Fig.2.6C. By clicking
corresponding hyperlink, we went to miRBase website for further detailed
introduction. Meanwhile, we can also search published articles related to miR-153-2.
A research has revealed that miR-153-2 was involved into the mechanism of major
type 1 diabetes, which leads to a further topic: if miR-153-2 could be a potential target
for diabetes treatment?
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A

B

C

Fig. 2. 6 Illustration of miRmo webserver interface and screening result. A-B:
Screening Result from PremiRmo with “ug” and “ua” as motif sequence, “Homo
Sapiens” as species, “RNAstructure” as prediction software, “Internal Loop” as
motif type. C: 2D image of miR-153-2 predicted by RNAStructure
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For searching in PDB dataset, there were total 128 entries were found, as shown in.
Certain amount of the query has the same location number, which indicate that the
RNA structure contained in these entries may be the same. For example, “UU:GA”
motif located in 3cma, 2otl and 1nji (PDB ID) and all of the “UU:GA” motif for these
three RNAs located in position 2553. Thus, it would not be surprising to find out that
they are partial 50S ribosome.
Besides, large rRNA complexed, we also obtained some relatively smaller structures
from the result, like 6qyz. It is a prohead RNA in bacteriophage. In this particular
structure, a single RNA forms intrastrand double helix structure, meanwhile, there are
five identical RNAs forming a pentagon complex. This structure was imaged by
electron microscopy and had a 4.6 Å resolution. With the help of miRmo, we quickly
locate the motif position and visualized by Pymol, as shown in Fig. 2.7B. The whole
structure was combined by the 5 same intra-strands double helix RNAs. As shown in
Fig. 2.7B, we may locate the target motif for further investigation. Meanwhile, we
can also extract one single RNA chain to process docking with small molecular or
protein. With the assistance of 3D structure, researchers may reveal more details in
future study.
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A.

B.

Fig. 2. 7 Illustration of motif “UUGA” in structure 6qyz, found by miRmo. A:
Result of motif screening in PDB database. B: 3D structure of 6qyz from PDB
database and enlarge area of “UUGA” motif.
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2.3.3 Time computing
The time consuming may varies from different server. Besides, searching
time for a single miRNA structure was different due to the length and the location of
target motif.
At beginning, the program ran on single computing thread which cause
searching time relative longer. Thus, we decided to induce GNU Parallel into our
server, which makes the algorithm could run on up to 5 threads. This dramatically
shorten the waiting time for a single searching process. Besides, we found out that
reading file is a dominant time-consuming part which was executed for each single
datapoint. Then, we addressed this issue by pre-processed our raw data by NumPy
and stored them into five npy format files, which leads to significantly shorten
reading process in total.
Based on the testing in Seadragon server at the University of Texas MD
Anderson Cancer Center, it roughly took 150 ms on average for a single miRNA
structure search with 1 core of Intel(R) Xeon(R) Gold 6132. With 5 cores of the
same CPU type, the entire searching time limited to 10 seconds for the example we
illustrate above.
However, it was not the case, when we integrate the Python files into
webserver, the speed was slow down due to the different CPU type and more
modules involved since JavaScript was used to build the web page for the server.
Typically, by using 5 CPU as computing power, when only screening Homo
sapiens pre-miRNA database for “UU:GA” internal loop motif as we described in
previous example, it took around 25 seconds for the webserver to print out all the
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available result. When screening the whole prediction dataset of RNAstructure, it
took around 6 minutes to complete searching process which is also tolerable

2.4 Discussion
In this section, we have presented a web server called miRNAmotifer for premiRNA motif screening. Motif will be crucial for the drug discovery and other
ncRNA research. It helps researchers to group and classify interested miRNAs
together. In this case, researchers may have a foresight about the potential side
effect during drug design and screening process.
In order to increasing the convenience and user experience, we collected and
built miRNA secondary structure database in advance and integrated into a
webserver. Besides, we set no limit to sequence direction of the input and the letter
of input as caps non-sensitive.
The main concern is about the webserver’s computing power. One thing
should be addressed here is that it will take a while for the webserver to carry out
the whole database screening process. A feasible way to fix this shortcoming is
increasing computing power by multi-CPUs usage in the webserver.
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Chapter 3: RNA Ensemble Generation & RNA/ligand Binding
Study
3.1 Introduction
In the previous chapter, we introduced a new webserver which was built
based on miRNA database to provide information about them for motif searching.
After gaining desired structure or miRNA molecules, it is also desirable to study
their dynamic structure and get further information about the aimed motif. Thus, in
this chapter we will introduce a practical method to gain RNA ensemble and study
RNA-ligand binding information.
Structure information is critical in computational docking process which
generally used to infer the interaction activity between ligands and receptors.
However, due to the large conformational change flexibility of RNA receptors, it is
still difficult to have conventional high-throughput screening for RNA receptors
[72].
Evidence [73, 74] shows that small molecules bind to RNA conformers from
preexisting dynamic ensembles. To study dynamic ensembles, residual dipolar
couplings (RDCs) has been used to biomolecular systems for a decade [75]. RDC is
an NMR technique which is used to provide inter-nuclei vector orientations
information, which can be used in long distance and certain time scales. Due to the
sensitivity of RDC to motions spanning the picosecond to millisecond, it can offer a
view of dynamic process of biomolecules. Based on that, our lab had developed an
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in-house software EnsembleGen which is able to obtain structure ensemble from the
pool of molecular dynamic (MD) snapshots based on measured RDCs values.
By using the ensemble structure, we continue to find out the binding pattern
between RNA I conformations and corresponding ligands.

3.2 Material and Methods
3.2.1 RNA structure ensemble generation

Coordinates of RNA I from the energy minimized average NMR structure
were used as the starting coordinates for a molecular dynamics (MD) simulation
with GROMACS 5.05 [76]. The RNA molecule was solvated in TIP3P water and
neutralized with sodium ions. After energy minimization, temperature and pressure
of the system were equilibrated for 100 ps before the production run which
continued for 100 ns. Snapshots were saved every 2 ps for further analysis.
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A.

B.

Fig. 3. 1 Structural models of RNA I with a non-canonical paired UU:GA motif. A.
The predicted secondary structure. B. The modeled 3D structure with UU:GA colored in
red.
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The structure ensemble was generated by comparing the population average
calculated RDC values with measured RDC values [73, 77]. This method minimizes
the number of conformers that satisfy all time averaged RDC data and identifies a
set of structures that represents unique and dominant populations across the entire
RNA structure landscape. The structure ensemble was obtained using an in-house
protocol termed EnsembleGen. The code and the detailed instruction are freely
available for download at https://imdlab.mdanderson.org/ressd/ressd.php. Combined
with Relax 4.0.3 [78], EnsembleGen uses one or more sets of RDC data to guide
selection of RNA conformers from the pool of MD snapshots.

3.2.2 RNA and Ligand Binding Study

The ensembles were primarily docked with compound ZN423 and its variants
by AutoDock Vina. The results of primary docking were used as initial files to
process secondary docking with rDock to generate 200 poses for each ligand. The
best fit of ligands was chosen for re-scoring with iMDLscore 2 [79] which was
previously published.

3.3 Result
3.3.1 Result of Molecular Dynamics and its ensemble

To explore the dynamics of RNA I and to generate ensemble structures that
RNA I might sample, unconstrained molecular dynamics simulations with explicit
solvent and counterions were performed using the minimized average coordinates of
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the solution structure. No significant conformational changes were observed through
100 ns of simulation. The RMSD between the starting structure and 50,000
snapshots from the simulation trajectory is illustrated in Fig. 3.2A.
Fig. 3.3 compares the calculated and measured RDC values, with overall
RMSD = 4.12 Hz. An ensemble of structures that reflects the unique and dominant
conformations of nucleotides across the entire RNA structure landscape was
constructed by determining the minimum number of RNA conformers that satisfy all
time averaged RDC data. The all heavy atom RMSDs between the minimized
average NMR structure and the individual structures contained in the ensemble
range 1.65-5.03 Å (Fig. 3.2B). The representative structures of RNA I from the
dynamic ensemble are shown in Fig. 3.2B.

41

A.

B.

Fig. 3. 2 Molecular dynamics and ensemble selection. A. The trajectory of MD
simulations. B. 8 of 20 selected RNA structures based on NMR RDC data as the
representative ensemble
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Fig. 3. 3 Comparison of in silico model and experimetnal RNA I structures.
Corrrelation of experimental RDC and calculated RDC data. R2=0.86 and
RMSD=4.12Hz.

Name
ZN423
ZN423-1
ZN423-2
ZN423-3
ZN423-4

R1
-H
-H
-H
-H
-NH2

R2
-H
-H
-H
-CONHNH2
-H

R3
-CONH2
-NHCOCH3
-CH(CH3)CH3
-H
-CONHNH2

iMDLScore
-11.17
-9.99
-10.32
-6.64
-10.48

Activity
active
inactive
inactive
inactive
inactive

Table 3. 1. Structure-activity relationship (SAR) of 423 series compounds
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3.3.2 Result of RNA and Ligand Binding Study

As shown in Table 3.1, evaluations with the RNA-specific scoring function
iMDLScore indicate that ZN423 has the highest rank of binding compared with the
four derivatives. This result is consistent with the inability of the derivatives to bind
RNA I.

3.4 Discussion
Although the RMSDs of the RNA I coordinates during the simulation do not
reveal dramatic structure changes, examination of individual snapshots shows that
localized conformational fluctuations occur throughout RNA I, particularly around
the mismatched bases. To improve the potential for success of the small molecule
virtual screen, a structure ensemble was created by incorporating RDCs into the
structure selection process using our in-house program EnsembleGen.
For RNA and ligand binding study, although the score difference itself is not
significant for ZN423 and ZN423-4 (e.g., -11.17 vs. -10.48), the loss of activity for
ZN423-4 is not surprising because of the possibility of the hydrazide group at R3 to
form intra-molecular hydrogen bonds in addition to the extra size of the hydrazine
moiety at R1 position.
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Chapter 4: Yukawa Scoring Function Development
4.1 Introduction
After getting desirable miRNAs with target motif (Chapter 2) from database
screening and obtained accurate ensemble structures (Chapter 3), the next step of the
pipeline is to screen potential binding ligands. In order to achieve this specific aim, in this
chapter, I will introduce a new modified and trained re-scoring model to assist our
docking and hit selection process.
4.1.1 Scoring Function
Evaluation of binding affinities of target receptor and ligands is crucial for
eliminating weak-binding or even non-binding small molecules from screening libraries.
Scoring function is primarily used to determine the interaction energy between two
molecule poses. As one of the major parts of docking process, the limitation and
inaccuracy of scoring function have become a key hurdle for virtual screening. To better
improve the efficiency of scoring function, we should firstly find out the two main goals
of scoring function: 1) good judgement of the native binding mode of the ligands to the
receptors, and 2) accurate prediction of interaction forces. Different theories have been
used to construct and optimize the scoring function. According to a review, the scoring
function can be classified into four major classes: force field-based, empirical,
knowledge-based and mixed.
Force field is usually used to describe the intramolecular and intermolecular
interactions among atoms. The description of force field are the potential energy
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functions which are decomposed into bond stretching energies, bond angle energies, bond
torsion energies, van der Waals potential energies, hydrogen bond, electrostatic energies
and so on.
Empirical scoring function made an assumption that the total free energy was
calculated by a serial of universal ideal free energy terms, such as ideal hydrogen bond
and ideal ionic bond energy. The factors of each free energy terms were modeled and
calculated from experimental measured binding affinity datasets. Multilinear regression
(MLR) was often used in the model training process.
Some scoring functions combined the advantage of both force field-based scoring
function and empirical scoring function. These functions usually contain the energies
terms which were from classic force fields, and meanwhile, inducing free energy terms
which were not in typical force fields. AutoDock scoring function [54] is one of the
combination example of force field and empirical type. The scoring function contains
terms describing the atomic interaction like Coulomb electrostatic potential energies, van
der Waals energies, hydrogen bond energies and desolvation energies. Then, the
coefficient of each parameters was obtained through MLR methods by fitting the known
experimental protein-ligand binding datasets.
Knowledge-based scoring functions are based on statistical analysis of the
structural information, such as pairwise-atom distance dataset, extracted from the
receptor and ligand interactions. DrugScore [80], PMF [81], PoseScore/RankScore [82]
are examples of knowledge-based scoring functions.
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4.1.2 Yukawa Potential
The Yukawa potential, which is also regarded as screened Coulomb potential
or Debye-Hückel potential, was proposed by Yukawa [83] in 1935. The expression
of Yukawa potential is:
Φ(r) = −+

!−"#

)

(1)

In the equation, r is the distance between interaction particles, , is the
Debye-Hückel screening parameter, + is used to describe the strength of the
interactions. When , = 0, which will leads to !−#$ = 1 and the expression becomes
the classic Coulomb potential where we set the + =

/! /"
0)

, with q1 and q2 are particle

charges, / is the dielectric constant of the solvent. When the , ≠ 0, it shows that the
screening effect is not only caused by its dielectric constant, but also the ionic
species in the solution which is described by the exponential term (!−#$ ).
For the application of Yukawa potential, it is not only used in the plasma
physics[84], but also in electrolytes and colloids which includes biological
macromolecules, like DNAs. For instance, a published paper [85] from Xiangyun
Qiu and his colleagues revealed that a Yukawa pair potential could be used to
describe the inter-DNA interaction, mainly charge repulsion based on the seminal
Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory. Similarly, with this
example, I will apply Yukawa potential, with other parameters, to predict the
interaction of RNA and small molecules.
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4.1.3 Review of Machine Learning
Machine learning is a set of computational algorithms which builds up a
mathematical model based on training dataset. It is a subset of artificial intelligence
(AI). Machine learning is often used in data mining and model training process. The
type of machine learning algorithm differs in how dataset was involved in training
process.
There are mainly three type of machine learning approaches: supervised
learning, unsupervised learning and semi-supervised learning. The main difference
between these three methods is whether there is output values for training dataset. If
each datapoint has desired output values as supervisory signal, then, it can be
classified as supervised learning. On the contrary, if the training dataset only has
input value and there is no output value, then it can be classified as unsupervised
learning. Normally, unsupervised learnings are used in data clustering, density
estimation and so on.
Besides machine learning approaches, machine learning also involve
different models, such as regression analysis, artificial neural network.
For regression analysis, it is a set of statistical methods to mimic the
relationship between a dependent variable and one or multiple independent variable.
Thus, they are commonly supervised learning process. Depend on the relationship,
regression analysis can be divided into two classes: 1. Linear regression. 2. Nonlinear regression. The general linear regression model can be expressed as equation
2. In the equation, b represent the weight of each parameters; /& presents the least
squares parameter estimates. When 1&' = 1, 2' would be the intercept.
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3& = 2% 1&% + 2* 1&* + ⋯ + 2'.% 1&'.% + 2' 1&' + /& (2)
When the relationship is not linear, regression analysis can also process nonlinear regression. For example, the data may fit better in exponential functions or
logarithmic functions.
For artificial neural network, it is an estimation of biological neural network
and consist of certain amount of neurons connection. With rapid growing field in
deep learning, researchers have developed several deep learning models [86-88]
including deep belief network (DBN) and convolutional neural network (CNN) for
multiple application purpose. The basic structure of CNN consists of input layer,
convolutional layer, pooling layer, fully connected layer and output layer. The input
layer of CNN, as the name suggests, is used as a starting point for the model to get
dataset input. The convolutional layer is the major block in CNN. This layer will
apply a filter to the input which result in an activation and feature map. Pooling
layer is another important building block of CNN which has function as
progressively reduce the dimension of the representation. It makes CNN more focus
on the feature value instead of position. The most common methods of pooling layer
are max pooling. Before present of output layer, in most of cases, there will be a
fully connected layer. The aim of fully connected layer is to combine all the
analyzed information which processed in previous blocks and makes the final
decision. Finally, the output layer will give the final result or decision.
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4.1.4 Overview of Yukawa scoring function development project
To improving the performance of AutoDock 4.2 scoring function, we induced a
new parameter, called Yukawa potential (A.K.A screened Coulomb potential) to replace
the static electronic potential. The replacement would lead to better description of
Coulomb interaction between RNAs and small molecules, since the Yukawa potential
better includes the impaction of atom types in the solution.
After modification of the scoring function, model training was processed to obtain
optimized coefficients in order to better fit the interaction of RNA and small molecules
ligands. Several training methods were used here, including multi-linear regression and
deep learning. We got training dataset from PDBBind and previous published papers.
Meanwhile, 90% entries were used as training dataset, and 10% entries were used as
validation dataset. The outcome of training process indicates that multi-linear regression
may be not suitable for current dataset which is relatively large. Nevertheless, the result
of deep learning shows relatively good fitness with both q-square and r-square larger than
0.5. It may be used for further prediction tools.
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4.2 Material and Methods: Benchmarking and Development
4.2.1 Benchmark Dataset
Replenishing of previous reported dataset, we compiled a new dataset which
contains 117 RNA-ligand binding affinity for RNA-specific scoring function training and
validation, as shown in Fig. 4.1. Meanwhile, it was also used in evaluation of visual
screening pipeline which integrated with new re-scoring function. Briefly, 45 RNAligand binding affinity values were collected from our previous work [62] and the
remaining 72 entries were carefully collected from newly updated database, PDBBind
[64] (http://www.pdbbind-cn.org). With recent version of database, we primarily
collected 125 entries of RNA binding complex in total. Because only dissociation
constant (Kd) can be used to calculate the binding free energy, we had to exclude 12
entries which were without Kd value. Furthermore, we excluded repeated entries and the
entries that had nucleotides as ligands which mainly bound through Watson–Crick base
pairs with the receptor. With known Kd value, the binding free energy were converted by
using the Equation (3) under the room temperature (300 K). The result shown in
Table.S2.
"6 = 78 9: #$ ;2
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(3)

Fig. 4. 1 Workflow of benchmark data processing.
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4.2.2 RNA-specific scoring function optimization
To improve the accuracy of scoring function, we optimized the empirical
scoring function which is from AutoDock4.2 scoring function [54], shown as
Equation (4). The previous AutoDock4.2 scoring function was mainly trained by
using protein-ligand complexes, which may lead to low accuracy of prediction result
for specific RNA-small molecules binding affinity.
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Based the equation, we induced a new parameter, known as screened
coulomb interaction (a.k.a Yukawa interaction) into the equation, which replace the
electronic interaction parameters. The new version of scoring function still keeps 5
parameters, as shown in Equation (5) and mainly calculated based on atom partially
charges and atoms distance. There is a new factor , , which contained in the
Yukawa interaction parameters, was determined in the paper [89] which was
published by Prof. Bohinc.
To achieve the modification of AutoDock scoring function in silicon, I obtained
source codes of PyAutoDock package from its official website
(http://autodock.scripps.edu). In the source code, there were 13 python scripts in the
folder which used for gridding and calculating different terms of free energies including
van der Waals, hydrogen bonds, electrostatic and desolvation. Meanwhile, file name with
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“AutoDockScorer” combined all the terms together and weighted each of them to sum up
as final binding affinity score.
In order to train the scoring function with our own dataset, unweighted score
should be calculated during the re-scoring process. Thus, it is necessary for us to modify
the term weights and change all of them into 1.
In addition, 5 RNAs, in the database, had multiple ensemble structures. To avoid
bias, we use the average score of the total ensemble structures for training purpose.
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4.2.3 Training and Validation
To gain the optimized scoring function, three different methods were used to
train the function with collected datasets. As mentioned in the previous section,
there were 117 entries in total. In the training, 90% of the entries would be
randomly chose for training and 10% left entries would be used for validation.
%*
Because there would be around G%%C
combinations for training and validation

datasets. Multiple combination would be conducted to get more accurate and precise
results.
Firstly, we used an R package called “fitting linear model” for the regression,
which was embedded in R studio. Both of these two training methods were repeated
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by 10000 times, which means 10000 different models were obtained during training
for each method.
The final method, which we chose to train the scoring function was deep
learning. Different training algorithm was used to get the best fit model. The first
neural network model, as illustrated in Fig. 4.2, we used is multilayer perceptron
(MLP) which composes one input layer, three hidden layers and one output layer. In
order to improve data integrity, we use “BatchNormalization” block as our input
layer which normalize our input dataset for further blocks. For our hidden layer, to
maximize the efficiency of regression model, we induce Long Short-Term Memory
(LSTM) block as our hidden layer architecture. We inspired by the model of “2019
CCF sales forecast of passenger vehicle segment market”
( https://github.com/zwkkk/2019-CCF-Sales-Forecast-of-Passenger-VehicleSegment-Market/blob/master/fusai/LSTM_Model_1. ipynb). The dense of first
LSTM layer is 300, and the dense of second LSTM layer is 425. “glorot_uniform”
was used for weight initialization. The third hidden layer is used for summarizing
the previous output, “tanh” activation function was used. For the output layer,
“PReLU” as activation function was used. To better describe the Neural network,
we also draw an architecture of LSTM neural network shown in Fig. 4.4A.
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NN_model = Sequential()
# The Input Layer :
NN_model.add(BatchNormalization(input_shape = (1,5,)))
# The Hidden Layers :
NN_model.add(LSTM(dense1, kernel_initializer = init,
return_sequences=True))
NN_model.add(LSTM(dense2, return_sequences = False,
kernel_initializer = init))
NN_model.add(Dense(5, kernel_initializer=init,activation='tanh'))
# The Output Layer :
NN_model.add(Dense(1, kernel_initializer=init))
NN_model.add(PReLU())
# Compile the network :
NN_model.compile(loss='mean_squared_error', optimizer=opt,
metrics=[q_square,'MSE'])
Fig. 4. 2 Algorithms of LSTM neural network
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The second neural network model was 1D convolutional neural network
shown in Fig. 4.3. It consists of 1 input layer, 2 convolutional layers, an additional
hidden layer and output layer. For the convolutional layers, we use “PReLU” as
activation function, and set dropout value to x which includes 0.25 and 0.5.
Meanwhile, we also use different kernel initializer includes ‘glorot_normal’,
‘lecun_normal’, ’he_normal’, ’he_uniform’, ’glorot_uniform’. After that
“MaxPooling1D” was used as pooling layer after each convolutional layer. Flatten
layer also applied for further sum up. Finally, we add a normalization layer before
the output layer and add “LeakyReLU” as activation function.
Code as shown in Fig. 4.3, we set the number of convolution kernels to 30,
and filter length to be 3. The architecture of CNN shown in Fig. 4.4B.
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model = Sequential()
# The Input Layer :
model.add(Conv1D(30,3,activation='relu',
kernel_initializer=init,input_shape=(5,1,)))
# The Hidden Layers :
model.add(PReLU())
model.add(Dropout(x))
model.add(MaxPooling1D())
model.add(Conv1D(nb_filter=30,filter_length=3,
kernel_initializer=init,border_mode='same'))
model.add(PReLU())
model.add(Dropout(x))
model.add(MaxPooling1D())
model.add(Flatten())
model.add(Dense(64,kernel_initializer=init,))
model.add(BatchNormalization())
model.add(LeakyReLU())
model.add(Dropout(x))
# The Output Layer :
model.add(Dense(1,kernel_initializer=init,))
model.add(Activation('linear'))
# Compile the network :
model.compile(optimizer=opt,
loss=q_square ,
metrics=['MSE'])
Fig. 4. 3 Algorithms of CNN.
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Fig. 4. 4 Architecture of Training Neural Network. A. convolutional neural
network of YuRD scoring function. Acknowledge: http://alexlenail.me/NNSVG/LeNet.html B. SLTM neural network of YuRD scoring function
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During the training process, coefficient of determination for training dataset
(Q2) was calculated for evaluating the fitness of models which were produced
during training process. The calculation equation was shown as in Equation (*).
Coefficient of determination for validation dataset (R2) was calculated for
evaluating the prediction accuracy of the models. The calculation equation was
similar to Equation (5). The only difference was the dataset used for determination.
H* ( IJ 7* ) = 1 −

∑#((# .?# )"
∑#((# .(̅ )"

(5)

4.3 Result
4.3.1 Multi-linear Regression Training Result

Three different training methods were used to get suitable model as RNAspecific scoring function. At beginning, normal multi-linear regression was used to
train the model. However, the result was found that one of the coefficient number
was negative which leads to confliction of real-world practice. The weight of
Yukawa, hydrogen bond, Van Der Waals, desolvation, and torsion energy is 0.0234, -0.1366, 0.0007, -0.3102, -0.0060, separately. Extra intercept, -20.69, also
applied in the model, shown in Fig.4.5. Meanwhile, both Q2 for regression model is
0.2766 and R2 is 0.0734.
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Fig. 4. 5 Score-binding affinity correlation for multi-linear regression training
outcome. A: Residuals vs Fitted plots. B. scores vs experimental measured binding
affinity

61

4.3.2 CNN Training Result

To improve the performance of model, we finally turned to use deep learning
methods as an alternative one. With trying to use different hyperparameters of the
neural network, we found that when we use 1D convolutional neural network, the
prediction is relative optimistic. Then, further adjustment of hyperparameter was
processed to get the best fitness of model for 1D convolutional neural network.
Different combination of datasets was used to increase performance and
stability of training process. We firstly got 117 spatial structures of RNAs and
corresponding ligands as one dataset. Among 117 structures average scores were
used for NMR conformations. Then, MD simulations was performed by MOE. 97 of
117 successfully generated restricted molecular dynamics, which consist of another
dataset. 5 snapshots were taken to consist another dataset. Thus, there were 4
datasets in total for training purposes.
During the hyperparameter optimization, we total constructed 7200 models
for each dataset. To better analyze the result, the number of models whose both q 2
and r2 larger than 0.5, 0.6 or 0.7 was counted. As shown in Table 4.1, with filter
standards increasing, only 97 RNA*5 datasets generate relatively qualified models.
To further evaluate the training methods, we plotted the q 2 and r2 value of top
10 r2 value models shown in Fig4.6A-B. Both 97 RNA * 5 dataset and all included
dataset has relatively stable outcomes. The q2 and r2 value plots were clustered
together. All of the plot of 97 RNA * 5 dataset were located in the upper right
corner in Fig4.6B, indicating the overall best model outcomes of training process.
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In addition, we also proceeded training process by using randomized score
dataset which means that the independent variables were corresponding to random
dependent variables during training. This is mainly to make sure the training process
did not overfitting. The comparison shown in Fig. 4.6C-D. Both 97 RNA * 5 dataset
and all included dataset has significantly higher q2 and r2 in models trained with
actual affinity score comparing to the q2 and r2 in models trained with randomized
affinity score. Overall, we decided to use 97 RNAs *5 datasets as training dataset
due to consideration of stability and prediction performance.
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Dataset
>0.5
>0.6
>0.7
97 RNAs
57
4
1
97 RNAs *5
1480
850
244
117 RNAs
18
0
0
All dataset included
717
134
0
Table 4. 1 Qualified Models Counting. The models which both of q2 and r2 were
larger than 0.5, 0.6 and 0.7, separately, were counted.

Fig. 4. 6 Top 10 Models of CNN Training Result of four various training dataset
Sorted Based on r2. A: Plot of q2 and r2; B: Plot of q2 vs r2; C: Box plot of q2 for
actual affinity score and randomized affinity score; D: Box plot of r2 for actual
affinity score and randomized affinity score.
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Among 7200 models of 97 RNAs *5 dataset training group, we picked a
model with overall highest q2 and r2 which is 0.75 and 0.86, respectfully. The
summary of chosen model shown in Table 4.2. There are 5365 parameters in total,
5237 out of 5365 is trainable parameter which were determined during training. The
number of convolutional filters were preset to 30. After flattening, the layer dense
was set to 64. The model used “Adam” as optimizer, the training initial mode as
glorot uniform. dropout rate was set as 0.25, batch size was set as 32 for the training
purpose.
With these hypermeters, we tried 50 different ways to randomly divide the 97
RNA * 5 datasets into 90% training dataset and 10% validation dataset. The result is
shown in Fig. 4.7. All 50 divisions result in promising result models with small
deviations.
To better reveal training process, loss history of both training process and
validation dataset were plotted in Fig. 4.8. It shows that the loss value of all of
randomized training dataset were approaching to 0, which indicate an evenly
random distributed prediction of the result. Comparing with all included dataset, the
97 RNA * 5 dataset has similar loss in training process, but better in validation
process which are more approaching to -1.
Prediction value of best model were plotted with actual value and fitted with
linear regression shown in Fig. 4.9. For training progress, the RMSE is 4.04 (Fig.
4.9A). And for validation dataset, the prediction RMSE is 3.17 (Fig. 4.9B).
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_________________________________________________________________
Layer (type)
Output Shape
Param #
=================================================================
conv1d_309 (Conv1D)
(None, 5, 30)
120
_________________________________________________________________
p_re_lu_309 (PReLU)
(None, 5, 30)
150
_________________________________________________________________
dropout_463 (Dropout)
(None, 5, 30)
0
_________________________________________________________________
max_pooling1d_309 (MaxPoolin (None, 2, 30)
0
_________________________________________________________________
conv1d_310 (Conv1D)
(None, 2, 30)
2730
_________________________________________________________________
p_re_lu_310 (PReLU)
(None, 2, 30)
60
_________________________________________________________________
dropout_464 (Dropout)
(None, 2, 30)
0
_________________________________________________________________
max_pooling1d_310 (MaxPoolin (None, 1, 30)
0
_________________________________________________________________
flatten_155 (Flatten)
(None, 30)
0
_________________________________________________________________
dense_309 (Dense)
(None, 64)
1984
_________________________________________________________________
batch_normalization_155 (Bat (None, 64)
256
_________________________________________________________________
leaky_re_lu_155 (LeakyReLU) (None, 64)
0
_________________________________________________________________
dropout_465 (Dropout)
(None, 64)
0
_________________________________________________________________
dense_310 (Dense)
(None, 1)
65
_________________________________________________________________
activation_155 (Activation) (None, 1)
0
=================================================================
Total params: 5,365
Trainable params: 5,237
Non-trainable params: 128
_________________________________________________________________

Table 4. 2. Parameter Summary of Overall Best CNN Model.
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Fig. 4. 7. Plot of q2 and r2 for 97*5 Dataset and All Dataset Included Group. Each
presents 50 different division of training dataset and validation dataset.
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Fig. 4. 8 The Comparison of the Loss History between the Actual Affinity and
Randomized Affinity for Overall Best CNN model. A: Training group; B:
Validation group
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Fig. 4. 9 Score-binding affinity correlation for Overall Best CNN with 97 * 5
dataset; A: training dataset B: testing dataset
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4.3.2 LSTM Training Result

Besides CNN deep learning methodology, we also tried LSTM learning. In
order to optimize the model training process, the same pipeline was applied. We use
4 different datasets for training purpose. Among 7200 models, as shown in Table
4.3, there were 6766 models of 97 RNAs * 5 dataset whose both q 2 and r2 were
larger than 0.5. Meanwhile, there were 122 models whose both q 2 and r2 were large
than 0.9. Comparing with another dataset, 97 RNAs * 5 had more consistent and
stable outcome. The same trends also indicated in Fig. 4.10A-B. There are less
variety among 97 * 5 dataset group and all dataset included group due to increased
training data points.
When comparing with randomized affinity score group, which can be
regarded as control group. All the dataset with actual affinity scores has significant
higher q2 and r2 as shown in Fig. 4.10C-D. However, the 97 RNAs * 5 and all
dataset included groups may had larger difference comparing with 97 RNAs and 117
RNAs group. This result further proves the function of MD simulation.
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Dataset
>0.5
>0.6
>0.7
>0.8
>0.9
97 RNAs
303
151
92
17
0
97 RNAs * 5
6766
6198
5144
3024
122
117 RNAs
620
315
85
10
0
All dataset included
6335
4965
2535
251
3
Table 4. 3 Qualified Models Counting. The models which both of q2 and r2 were
larger than 0.5, 0.6, 0.7, 0.8 and 0.9, separately, were counted.

Fig. 4. 10 Top 10 Models of LSTM Training Result of four various training
dataset Sorted Based on r2. A: Plot of q2 and r2; B: Plot of q2 vs r2; C: Box plot
of q2 for actual affinity score and randomized affinity score; D: Box plot of r2 for
actual affinity score and randomized affinity score.
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Among 7200 models of 97 RNAs *5 dataset training group, we picked a
model with overall highest q2 and r2 which is 0.90 and 0.97, respectfully. The
summary of chosen model shown in Table 4.4. There are 638582 parameters in
total, 638572 out of 638582 is trainable parameter which were determined during
training. After batch normalization, there are two layers of LSTM with 300 and 150
dense, separately. The LSTM layers follows with a 5 dense layer and 1 dense layer
as output layer with PReLU activation layer. The model used “RMSprop” as
optimizer, the training initial mode as “the normal”, batch size was set as 32.
With these hypermeters, we tried 50 different ways to randomly divide the
dataset into 90% training dataset and 10% validation dataset. The result is shown in
Fig. 4.11. All 50 divisions result in promising result models with small deviations
for 97 RNA * 5 datasets comparing with all dataset included group.
To better reveal training process, loss history of both training process and
validation dataset were plotted in Fig. 4.12. It shows that the loss value of all of
randomized training dataset were approaching to slightly below 0, which indicate an
evenly random distributed prediction of the result. Comparing with all included
dataset, the 97 RNA * 5 dataset has similar convergence speed for both in training
progress and validation dataset.
Prediction value of best model were plotted with actual value and fitted with
linear regression. As shown in Fig. 13A-B, the slope of linear fitting is fairly close
to 1 which indicate small RMSE values. As result, for training progress, the RMSE
is 2.53 (Fig. 13A). And for validation dataset, the prediction RMSE is 1.42 (Fig.
13B).
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_________________________________________________________________
Layer (type)
Output Shape
Param #
=================================================================
batch_normalization_18 (Batc (None, 1, 5)
20
_________________________________________________________________
lstm_35 (LSTM)
(None, 1, 300)
367200
_________________________________________________________________
lstm_36 (LSTM)
(None, 150)
270600
_________________________________________________________________
dense_35 (Dense)
(None, 5)
755
_________________________________________________________________
dense_36 (Dense)
(None, 1)
6
_________________________________________________________________
p_re_lu_18 (PReLU)
(None, 1)
1
=================================================================
Total params: 638,582
Trainable params: 638,572
Non-trainable params: 10
_________________________________________________________________

Table 4. 4. Parameter Summary of Overall Best LSTM Model.
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Fig. 4. 11 Plot of q2 and r2 for 97*5 Dataset and All Dataset Included Group. Each
presents 50 different division of training dataset and validation dataset.
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Fig. 4. 12 The Comparison of the Loss History between the Actual Affinity and
Randomized Affinity for Overall Best LSTM model. A: Training group; B:
Validation group
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Fig. 4. 13 Score-Binding Affinity Correlation for Overall Best LSTM with 97 * 5
dataset; A: training dataset B: testing dataset
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4.3.3 Result Comparison

When comparing the result of multi-linear regression and deep learning
methods, both of the deep learning methods has more advantages in q-square and rsquare outcomes. Both of deep learning methods are significant improved both q2
and r2. Meanwhile, LSTM seems have more robust prediction result than CNN with
smaller RMSE value of validation prediction as shown in Table 4.5.

Training
Method

Coefficient of
Determination for
Training Dataset (Q2)

Coefficient of
determination for
validation dataset (R2)

RMSE of
Validation
Prediction

Multi-linear
Regression

0.28

0.07

5.46

CNN

0.75

0.86

3.17

LSTM

0.90

0.97

1.42

Table 4. 5 Associated R2, Q2 and RMSE of Prediction of three training methods

To be more convincing, the results of AutoDock and rDock are also used as
comparisons. After plotting prediction result, as shown in Fig.4.14, both of
AutoDock scoring function and rDock scoring function has relatively large RMSE
when comparing with experimental measured data. The slop of linear fitting of plot
is near 0, which indicating no correlation between prediction score and experimental
measured data.
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A.

B.

Fig. 4. 14 Score-Binding Affinity Correlation for current scoring function; A:
AutoDock4.2 B: rDock
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4.4 Discussion
RNA is a potential, but less systematically investigated therapeutic target
comparing with proteins, due to lack of specific docking software for structurebased drug design. As shown in Table 4.6, when using AutoDock4.2 scoring
function to re-score 117 RNAs and ligands binding affinities, we found out that
electrostatic interaction term played an important role in prediction. To address this
issue, we have re-arranged AutoDock4.2 scoring function with Yukawa potential.
The scoring function was trained with 117 RNA-ligand binding affinity datasets by
three different machine learning methods.
Although the RMSE value is relatively low for multi-linear regression model,
the data did not fit to the model well, overall. Reflecting from Fig. 4.5A, the
residual distributed widely at both side of the middle line, which leads to less fit of
model in training dataset. The low q-square and r-square value of the model also
indicate that the relationship between parameters and final binding affinity may not
be linear. The other possible explanation would be due to the parameter is not
totally independent to each other since all of them related to the atom distance.
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Receptor
1AM0
1ARJ
1BYJ
1EHT
1EI2
1F1T
1F27
1FMN
1J7T
1KOC
1KOD
1LC4
1LVJ
1NEM
1NTB
1PBR
1Q8N
1QD3
1TOB
1U8D
1YKV
1YRJ
2B57
2BE0
2BEE
2ESI
2ET8
2F4S
2F4T
2F4U
2FCZ
2FD0
2G5K
2G9C
2KTZ
2KU0
2KX8
2L94
2LWK

AutoDock4.2Score
-2.76
6.07
8.62
4.48
12.24
-5.38
-1.93
-2.61
6.58
6.02
1.16
10.40
-1.72
14.20
3.91
7.35
-5.81
9.72
10.75
6.13
-6.21
9.28
6.53
9.98
16.89
9.09
9.36
9.49
10.41
7.69
10.03
7.81
15.60
-0.98
0.86
0.68
4.98
9.09
-0.07

estat
-0.85
-0.91
-0.90
-0.15
-2.49
-0.01
-0.37
-0.83
-4.48
-1.91
-2.75
-2.66
-0.51
-4.55
-4.04
-2.56
0.00
-6.09
-2.50
-2.59
-0.53
-3.27
-4.35
-3.62
-4.06
-2.75
-3.64
-3.35
-3.71
-3.87
-2.13
-2.66
-3.25
-3.54
-1.17
-0.67
-0.57
-0.46
-0.15
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hb
7.72
-5.25
-8.44
-9.98
-12.41
-18.77
-8.93
-15.37
-2.73
-6.82
-5.65
-5.46
-6.34
-17.65
-12.79
-14.37
-14.60
-15.32
-11.13
-6.24
-14.38
-12.43
-9.57
21.99
-13.01
-3.20
-6.38
-4.57
-10.85
-8.93
-9.14
-12.41
-10.16
-7.81
-12.90
-11.53
-5.97
-7.29
-4.84

vdw
7.14
5.04
5.63
5.67
7.55
6.28
3.28
7.48
7.53
5.45
3.98
7.73
4.19
10.53
9.01
8.50
5.98
9.82
7.23
5.85
5.47
7.68
6.91
9.07
8.89
8.29
5.81
5.84
7.19
7.28
7.43
8.27
6.78
5.14
5.88
5.42
3.56
3.78
3.79

dsolv
2.68
2.09
3.88
0.00
6.56
0.60
1.79
3.58
6.56
2.09
2.09
4.77
1.49
6.56
5.07
6.56
1.49
6.56
4.77
0.00
2.39
4.77
0.60
8.05
8.35
5.07
3.28
3.28
6.56
6.86
4.77
8.05
4.77
0.89
2.09
2.09
1.79
3.88
1.10

tors
13.93
7.03
8.79
0.02
11.45
-17.30
-6.17
-7.74
13.46
4.84
-1.17
14.78
-2.89
9.10
1.15
5.48
-12.94
4.69
9.14
3.15
-13.28
6.04
0.12
45.48
17.06
16.50
8.44
10.69
9.59
9.03
10.96
9.06
13.73
-6.30
-5.24
-4.02
3.79
9.00
-0.17

2MXS
2N0J
2O3V
2O3W
2O3X
2OE8
2TOB
2XNW
2XO0
2XO1
2YDH
2YGH
3DIL
3DS7
3E5C
3FO4
3FO6
3FU2
3G4M
3GAO
3GER
3GES
3GOG
3GOT
3GX3
3GX5
3GX7
3LA5
3MUM
3MUR
3MXH
3NPN
3OWZ
3Q3Z
3Q50
3SD1
3SD3
3SKI
3SLM
4AOB

10.16
9.89
7.69
7.60
7.20
9.30
10.55
0.47
-1.28
4.78
1.45
1.43
12.46
0.75
-0.35
6.56
5.71
3.04
6.15
8.36
4.93
5.45
6.32
6.89
1.77
0.17
1.01
-0.29
-5.87
-5.82
-5.72
-0.46
-1.97
-4.86
2.91
-3.78
8.75
-2.86
-13.20
1.20

-2.98
-3.48
-3.29
-1.97
-3.94
-3.47
-4.79
-2.36
-2.44
-2.91
-2.11
-3.82
-2.17
-3.58
-1.24
-3.53
-3.19
-3.06
-2.88
-2.10
-3.10
-3.51
-3.36
-3.28
-2.66
-3.43
-3.37
-1.85
-4.49
-3.82
-4.11
-2.15
-1.74
-2.28
-2.35
-3.58
-2.99
-3.71
-2.18
-2.88
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-12.44
-11.06
-8.83
-7.03
-7.35
-9.56
-13.20
-7.48
-6.38
-9.14
-13.27
-14.62
-8.97
-11.50
-11.07
-9.64
-8.43
-3.88
-6.88
1.58
-9.58
-10.02
-9.67
-9.27
-14.00
-14.51
-14.18
-3.66
-23.02
-23.35
-23.86
-14.65
-4.04
-19.53
8.46
-10.00
-10.30
-12.11
-9.89
-11.08

8.17
7.40
5.53
5.46
6.83
8.93
9.08
5.32
4.24
5.80
8.17
7.95
5.18
5.44
6.56
6.22
6.76
6.24
5.96
6.63
5.58
6.83
6.38
6.32
7.93
8.04
8.17
4.04
12.89
12.93
13.22
7.23
2.83
11.33
6.65
5.69
5.58
6.64
8.27
8.15

6.71
4.77
5.67
6.56
4.77
4.77
4.77
0.60
0.60
0.30
3.58
3.58
2.39
1.49
3.58
0.00
0.60
0.89
0.30
0.00
0.00
0.60
0.00
0.00
3.58
3.58
3.58
0.30
2.39
2.39
2.39
3.58
0.60
2.39
0.89
1.79
1.49
1.19
1.79
3.58

9.62
7.52
6.77
10.63
7.52
9.98
6.41
-3.46
-5.26
-1.17
-2.18
-5.49
8.89
-7.41
-2.53
-0.40
1.45
3.24
2.65
14.47
-2.17
-0.65
-0.33
0.66
-3.38
-6.16
-4.79
-1.47
-18.09
-17.68
-18.08
-6.45
-4.33
-12.95
16.58
-9.88
2.52
-10.85
-15.22
-1.03

4ERJ
4ERL
4FE5
4JF2
4KQY
4L81
4LVV
4LVW
4LVX
4LVY
4LVZ
4LW0
4LX5
4LX6
4NYA
4NYB
4NYC
4NYD
4NYG
4OQU
4QK8
4QK9
4QLM
4QLN
4TS0
4TS2
4W90
4XWF
4YAZ
4YB0
4ZNP
5BTP
5C7U
5C7W
5KPY
5UEE
5V3F

4.16
4.43
6.29
3.47
0.28
1.18
-6.43
-0.94
-1.97
3.10
8.31
8.04
-2.06
-1.36
-1.86
1.32
-1.76
5.69
-2.66
1.31
-19.68
-19.31
-17.82
-17.76
3.54
-16.55
-1.22
-3.70
-14.43
-8.26
-10.17
5.94
5.84
4.68
-3.82
-3.85
-5.86

-1.25
-2.25
-2.60
-3.14
-3.59
-2.84
-3.46
-2.92
-3.40
-2.60
-2.37
-1.97
-3.92
-3.44
-0.40
-0.59
-0.32
-0.92
-0.12
-2.69
-4.11
-4.27
-4.56
-1.60
-0.87
-3.34
-0.86
-3.42
-3.84
-3.40
-3.11
2.78
-1.43
-1.58
-0.02
-0.04
-1.10

-7.29
-7.92
-3.41
-9.91
-14.79
-14.52
-10.19
-7.59
-9.33
-9.73
-6.68
-3.20
-9.92
4.81
-7.80
-9.33
-7.22
-8.09
-6.33
-14.89
-20.18
-21.16
-20.37
-19.59
-12.96
-18.68
-4.42
-23.63
-17.93
-12.08
-11.37
-7.14
-7.88
-8.97
-3.71
-3.69
-23.30

3.76
3.85
5.90
5.66
7.99
8.00
5.83
4.40
5.41
5.10
5.60
5.03
5.67
5.71
3.52
3.41
3.17
5.17
3.11
8.01
10.56
10.94
11.13
10.36
6.30
10.07
2.43
12.96
13.76
7.69
6.40
5.73
5.56
5.05
1.90
1.90
8.43

2.09
2.09
0.00
0.89
3.58
3.58
2.54
0.30
1.49
1.49
0.60
0.30
0.60
0.30
0.89
0.89
0.00
0.00
1.79
3.58
1.19
1.19
1.79
0.60
0.89
1.79
2.98
1.79
1.79
2.68
2.39
0.00
0.00
1.79
5.37
5.07
6.26

Table 4. 6 Initial AutoDock 4.2 scores of RNA-ligand Binding affinity

82

1.46
0.20
6.18
-3.02
-6.54
-4.61
-11.72
-6.75
-7.79
-2.64
5.46
8.21
-9.63
6.02
-5.64
-4.29
-6.13
1.85
-4.20
-4.68
-32.22
-32.61
-29.82
-27.99
-3.09
-26.70
-1.08
-16.01
-20.66
-13.36
-15.86
7.30
2.09
0.98
-0.29
-0.60
-15.56

For CNN training result, due to the training dataset focus on the range of -30
kJ/mol to -40 kJ/mol, if the dataset locate at this range would be more accurate than
the dataset which are not locate in this range. This also indicate that more data point
needed for improving the performance of prediction model in more large ranges. In
LSTM model, it also shows trending that with away from (-30 kJ/mol, -40kJ/mol)
region, the fitting starts to drop and the prediction error starting to increasing, which
suggests the importance of data point distribution.
Meanwhile, in order to increase the stability and performance of the result,
we introduced a novel methodology to increase the training sample of dataset by
using MD simulation. The multi-snapshot of MD simulation significantly increased
the stability and performance of the dataset during training process.
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Chapter 5: Summary and Future Direction
5.1 Summary of miRmo webserver
In Chapter 4, we introduced a miRNA motif screening webserver which can be
used to find same motif in current database. The webserver basically includes two parts:
database and searching algorithm.
The database has three sets which came from three different secondary structure
prediction tools. We collected primary structure of current known miRNAs from
miRBase. Then, we had the miRNAs from Homo sapiens as an independent sub-set.
After the classification, the secondary structure of each miRNA was predicted separately
by RNAstructure, RNAfold and CentroidFold. Meanwhile, we created a
straightforward image of every secondary structure for users to download.
For searching algorithm, Python was used as programming language. Either
input or output was designed as user-friendly manner. Users is able to choose their
motif type, searching species, and prediction tools which they trust.

5.2 Future direction of miRmo webserver
With limiting computing powers, there is still lot of room for miRmo to improve.
Although the speed of screening is acceptable, several minutes of waiting for whole
species screening sometimes is not a good interaction with users. There are several
methods to solve these problems. The first idea came up to my thought is using more
computing power for our webserver. Due to parallel searching design, the algorithms
would finish the whole screening process with much shorter term.
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There also another way to improve the speed. We could extract the important
information of miRNAs secondary structure and build a tree data structure to store the
information. With the reorganization, the searching algorithm will process the screening
in a much shorter term.
Besides improving searching speeds, we can also expand our database to other
ncRNAs. However, the whole limits here is about the complete database and accurate
secondary structure predictions, because some ncRNAs normally have relatively large
length comparing with miRNAs, which increasing the difficulty of accurate prediction.

5.3 Summary of RNA Ensemble Generation & RNA/ligand Binding
Study
In Chapter 2, we mainly introduced the application of MD simulation to
generate snapshots of RNA and combining with RDC dataset to using EnsembleGen
software generate ensemble conformations. After that, we also using the structure of
ensemble conformations to study the RNA-ligand binding feature. Using the current
rescoring function to distinguish the binding mode of RNA and ligands with similar
structures.

5.4 Future direction of RNA Ensemble Generation & RNA/ligand
Binding Study
Besides using this tool in the RNA-ligand binding study, it also can be used for
developing pipeline to target highly flexible RNA receptors. However, technical
bottleneck of miRNA extraction and crystallization is still existing. The software still
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needs the following condition to generate ensemble conformations: (1) proper MD
simulations for generate snapshots. (2) RDC values for ensemble conformations.
One direction in the future for improvement is that we can developed a software
to generate ensemble conformations solely depended on RDC values. Meanwhile, we can
always combine other NMR data into the ensemble generation for more accurate result.

5.5 Summary of Yukawa scoring function development
In Chapter 3, we mainly introduced a new pipeline of molecular docking.
The pipeline consists of one docking process and one new re-scoring process.
According to the pipeline, the receptor RNA would dock with ligand dataset
primarily by rDock. After getting poses, the conformation of complex would be rescored by our new re-scoring function, YuRD to get a final score.
The new re-scoring function was based on a scoring function frame from
AutoDock 4.2. We replaced one of the parameters, electrostatics, with screened
Columbo potential energy which had been reported to be used in biophysics to
describe the interaction of nucleotides.
Different training methods were used to obtain best weights of each
parameters. We proceed CNN and LSTM training methods. The evaluation results
showed that the deep learning methodologies were the winner. Between them,
LSTM seems has better outcome. Meanwhile, when inducing more molecular
dynamics structure, the training models has more stable outcome.During the deep
learning process, several high-quality models were saved for further use.
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5.6 Future direction of Yukawa scoring function development
There is still huge remaining space to improve the accuracy of prediction.
Different strategy can be used in docking pipeline. As a docking pipeline, the result of rescoring would not have an impact on the searching algorithms. Thus, instead of having a
re-scoring function, it also a good idea to integrate the new scoring function into the
existing docking software. As introduced in Chapter 1, the new scoring function would
direct the searching algorithm to search most optimal conformations.
Meanwhile, as a training dataset of deep learning, the size of dataset was
relatively small. However, with the increasing interest of miRNA and other ncRNA,
more and more binding affinity data would be tested.

5.6.1 Integration of re-scoring function into rDock
After having new scoring function models, the next step was to integrate the
model into a pipeline in order to work together with rDock. In that case, the rescoring function model can be used into RNA-specific drug virtual screening.
The main pipeline, as shown in Fig. 5.1, consists of two parts, rDock primary
docking part and modified PyAutodock re-scoring part. The first part was that the
receptor was primary docked with ligand database by using rDock, which would
produce 200 different poses for each single ligand. Then, based on the current
docking result, PyAutoDock package would calculate the five parameters score,
which has shown in Equation (5) of the interaction between each pose of ligand and
receptor. After that, the final affinity score would be calculated by inputting the
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five-parameter score into the trained model. According to the final affinity score,
the hit small molecules would be choosing for further experimental validation.

Fig. 5. 1 Illustration of integration of re-scoring function model into rDock for hits
selection process

Fig. 5. 2 Illustration of cross docking and hits selection process
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5.6.2 Evaluation of Virtual Screening
To evaluate the quality of the virtual screening pipeline, which was
mentioned above, cross docking validation method was used with existing 117
entries dataset, which was shown in Fig. 5.2.
In the evaluation, every entries of dataset will be docked and re-scored with
the other 116 ligands. According the final result of affinity score, top 10 would be
chose as final hit molecules. At this point, the number of correct hit molecules
would be recorded, and the hit ratio would be calculated based on Equation (6).

!"# %&#"' =

!"# %&'(#) *+ ,*))#-. /0. 1*2#-2&#3
!"# .*.42 %&'(#) *+ 54.43#.

(6)

5.7 Summary of the Whole Project
In order to better assist RNA related research, we started this bioinformaticsbased projects. The project begins with building webserver which aims to find miRNAs
with target motifs. In this webserver, we combined the sequences data from miRBase and
structure information from PDB database. Users are able to screen out potential target
miRNAs with desired motifs. Meanwhile, we also provided matched structure
information, if valid, to the users for further detailed 3D structure of the motif.
Once having detailed structure information, our second part of project illustrate a
practical example of using NMR RDC dataset for miRNA structure study and ligand
binding affinity study.
When evaluating the binding affinity, it is essential to use accurate scoring
function models. That’s when our third part of project involved here. We developed a
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new scoring function by switching electrostatic potential to Yukawa potential. And
meanwhile, we use neural network for training purpose to get more robust models.
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Appendix
Motif
type

Example

Input Type

Only Hairpin
Hairpin
Neighbor
sequence
included

Only Bulge
Bulge
Neighbor
sequence
included
Same
length

Only
internal
Loop

Different
length

Only
internal
Loop

Internal
Loop

Mismatch

Only
Mismatch

Left hand
side
examples
cuccaga
agaccuc
gucuccagagc
cgagaccucug
cg-ug
gu-gc
ua
au
g-a
a-g
cuau
uauc
aa
aa
gc
cg
u
u
uuc
cuu
u
g

Right hand
side
examples
cuccaga
agaccuc
cg-ug
gu-gc
gucuccagagc
cgagaccucug
ua
au
cuau
uauc
g-a
a-g
gc
cg
aa
aa
uuc
cuu
u
u
g
u

Instruction: As long as the sequence is in order, it doesn’t matter if the blank or the sequence is reversed, which
means all the following input will work. Meanwhile, neighbor sequence is NOT allowed in Internal Loop motif
screening. For mismatch, two inputs should have THE SAME LENGTH.

Table A. 1 motif searching instruction with examples.
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PDB ID

Type

1AM0
1BYJ
1EHT
1EI2
1F1T
1F27
1FMN
1J7T
1KOC
1KOD
1LC4
1LVJ
1NEM
1NTB
1PBR
1Q8N
1QD3
1TOB
1U8D
1YKV
1YRJ
2BE0
2BEE
2ESI
2ET8
2F4T
2FCZ
2FD0
2G5K
2KTZ
2KU0
2L94
2O3V
2OE8
2TOB
2YGH
3DIL
3GER
3GX3
3GX5
3GX7
3LA5
3Q3Z

NMR
NMR
NMR
NMR
Crystal
Crystal
NMR
Crystal
NMR
NMR
Crystal
NMR
NMR
Crystal
NMR
NMR
NMR
NMR
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
NMR
NMR
NMR
Crystal
Crystal
NMR
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal

Binding Free
Energy(KJ/mol)
-28.5
-32.73
-36.5
-34.23
-42.23
-29.8
-35.9
-38.47
-24.1
-23.8
-33.06
-39.97
-39.9
-34.46
-38.2
-35.02
-30.03
-52.2
-35.24
-28.72
-30.91
-39.55
-40.2
-27.25
-27.99
-32.49
-28.62
-43.04
-36.19
-28.98
-32.08
-19.78
-30.21
-36.19
-51.2
-37.38
-40.2
-34.75
-23.83
-39.55
-25.89
-34.46
-49.72
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Dissociation constant
2.0 µM(room temperature)/0.01 µM( 4 ℃)

0.04µM
6.0µM
0.2±0.042µM

1.5µM / 2±0.22µM

1µM
0.8µM
5.4±4µM; 0.92µM(U24C mutant)
0.732µM
10µM
2±0.20µM / 6.3µM
0.1µM
0.13µM
18µM
7.8µM / 19±1µM
2.2±0.1µM
10.4±1.4µM
0.032±0.007µM
0.5µM
9µM
2.6µM
360±26µM
0.5µM
0.31±0.06µM
0.10±0.03µM(with K+ and Mg2+)
0.89±0.06µM
71±2µM
0.13±0.01µM
31±1µM
1±0.016µM
0.0022±0.0002µM

3SD1
3SKI
1ARJ
2B57
2F4S
2F4U
2G9C
2KX8
2LWK
2MXS
2N0J
2O3W
2O3X
2XNW
2XO0
2XO1
2YDH
3DS7
3E5C
3FO4
3FO6
3FU2
3G4M
3GAO
3GES
3GOG
3GOT
3MUM
3MUR
3MXH
3NPN
3OWZ
3Q50
3SD3
3SLM
4AOB
4ERJ
4ERL
4FE5
4JF2
4KQY
4L81
4LVV
4LVW
4LVX

Crystal
Crystal
NMR
Crystal
Crystal
Crystal
Crystal
NMR
NMR
NMR
NMR
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal

-27.25
-40.2
-17.23
-40.92
-44.62
-27.11
-30.03
-32.73
-29.86
-30.39
-37.22
-32.08
-24.7
-22.97
-23.53
-22.97
-37.38
-25.32
-53.09
-35.28
-26.64
-44.22
-30.76
-25.32
-26.99
-26.53
-31
-55.58
-44.93
-62.94
-43.04
-31.33
-49.9
-27.25
-19.65
-36.24
-14.41
-18.63
-35.24
-44.49
-44.34
-36.68
-36.19
-24.01
-27.25

18±1µM
0.1±0.01µM (20mM Mg2+)
1mM
75nM
17nM
19µM
5.9µM
2µM
6.31µM
5.1µM
0.33µM
2.6µM
50µM
100µM
80µM
100µM
0.31µM
39µM
0.57nM
0.72µM
23µM
20nM
4.4µM
39µM
20µM
24µM
4µM
0.21nM
15nM
11pM
32nM
3.5µM
2.05nM
18µM
379µM
0.49µM
3100µM
570µM
0.732µM
17.9nM
19nM
0.41µM
0.5µM
66µM
18µM
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4LVY
4LVZ
4LW0
4LX5
4LX6
4NYA
4NYB
4NYC
4NYD
4NYG
4OQU
4QK8
4QK9
4QLM
4QLN
4RZD
4TS0
4TS2
4W90
4XWF
4YAZ
4YB0
4ZNP
5BTP
5C7U
5C7W
5KPY
5UEE
5V3F

Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal
Crystal

-22.73
-36.19
-29.27
-38.32
-40.33
-33.45
-22.9
-20.4
-18.23
-33.45
-36.68
-37.46
-37.46
-41.24
-31.8
-47.02
-36.04
-36.04
-41.78
-34.27
-34.64
-34.64
-30.6
-36.25
-42.37
-42.03
-31.06
-21.24
-48.95

110µM
0.5µM
8µM
213nM
95nM
1.5µM
103µM
280µM
670µM
1.5µM
0.41µM
300nM
300nM
66nM
2.9µM
6.5nM
530nM
530nM
53.1nM
1.08µM
0.93µM
0.93µM
4.7µM
487nM
42nM
48nM
3.9µM
0.2mM
3nM

Table A. 2 Experimental binding free energy used for benchmarking, training and
optimizing YuRD score function
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